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Abstract: We hypothesized that clinically sized (15 mm thick),compact cardiac
constructs containing physiologically high density of viable cells (108 cells/cm3)
can be engineered in vitro by using biomimetic culture systems capable of providing
oxygen transport and electrical stimulation, designed to mimic those in native heart.
This hypothesis was tested by culturing rat heart cells on polymer scaffolds, either
with perfusion of culture medium (physiologic interstitial velocity, supplementation
of perfluorocarbons), or with electrical stimulation (continuous application of bi-
phasic pulses, 2 ms, 5 V, 1 Hz). Tissue constructs cultured without perfusion or elec-
trical stimulation served as controls. Medium perfusion and addition of perflu-
orocarbons resulted in compact, thick constructs containing physiologic density of
viable, electromechanically coupled cells, in contrast to control constructs which
had only a  100 m thick peripheral region with functionally connected cells. Elec-
trical stimulation of cultured constructs resulted in markedly improved contractile
properties, increased amounts of cardiac proteins, and remarkably well developed
ultrastructure (similar to that of native heart) as compared to non-stimulated con-
trols. We discuss here the state of the art of cardiac tissue engineering, in light of the
biomimetic approach that reproduces in vitro some of the conditions present during
normal tissue development.
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1. INTRODUCTION
Cardiovascular disease is responsible for a preponderance of health problems,
and its impact is expected to grow further as the population ages. Heart disease and
stroke, the principal components of cardiovascular disease, are the first and the
third leading cause of death in developed countries, accounting for nearly 40 % of
all deaths. Congential heart defects, which occur in nearly 14 of every 1000 new-
born children,1 are the most common congenital defects and the leading cause of
death in the first year of life.2,3 About 61 million Americans (almost one-fourth of
the population) live with cardiovascular diseases, such as coronary heart disease,
congenital cardiovascular defects, and congestive heart failure.4
Tissue engineering has emerged over the last decade as an interdisciplinary
field with tremendous potential. Substantial progress has been made in areas of
biopolymers,5 cell-material interactions6 and bio-mimetic culture devices.7 Func-
tional tissues have been developed and implanted in vivo, including (but not lim-
ited to) cartilage,8 bone,8 bladder10 and blood vessels.11, 12 Engineered tissues can
also provide high-fidelity models for basic studies of cell function and tissue de-
velopment, and responses to genetic alterations, drugs, hypoxia, and physical stim-
uli.13, 14 However, fundamental and all-encompassing problems remain. One of
the most important ones is mass transfer into the tissue beyond the  100 m thick
peripheral region, both during the in vitro cultivation and following implantation
in vivo. This explains why tissue engineering has been most successful with tissues
that are either thin (e.g. bladder) or have low oxygen requirements (e.g., cartilage).
Our current inability to vascularize and perfuse thick cell masses has hindered ef-
forts to build many types of tissues, including, most critically, cardiac muscle.
Three-dimensional tissue constructs that express structural and physiological
features characteristic of native cardiac muscle have been engineering using fetal
or neonatal rat cardiac myocytes (CM) cultured in collagen gels with mechanical
stimulation,1518 on collagen fibres,19 fibrous polyglycolic acid scaffolds2024
and porous collagen scaffolds.2527 Cells were seeded onto scaffolds and culti-
vated in dishes,21, 24, 25, 28 Oxygen dissolved in medium was transported to the
cells by molecular diffusion, which provided enough oxygen for an approximately
100 m thick outer layer of functional tissue but not for the construct interior,
which remained relatively acellular.17, 20, 21, 24 Construct cultivation in perfused
cartidges merkedly improved the uniformity of cell distribution, but the overall
cell density remained low due to the diffusional limitations of oxygen supply dur-
ing scaffold seeding.22, 23 To overcome this problem, we recently employed a
bioreactor with interstitial flow of culture medium that provides sufficient oxygen
supply during both seeding and cultivation, and thereby enables the maintenance
of physiologic densities of viable cardiac myocytes.27 In a separate recent study,
we enhanced excitation-contraction coupling of cardic myocytes in cultured con-
structs by applying cardiac-like electrical stimulation.14
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Key factors necessary for production of functional cardiac tissue are:
 Biodegradable and biocompatible scaffolds that provide adequate mass
transfer, vascularization, and transduction of mechanical and electrical sig-
nals
 Culture systems that promote differentiated function and excitation  con-
traction coupling of cardiac cells
 Functional vascular networks embedded into the cardiac muscle to promote
nutrient transfer, angigiogenesis and integration with the host vasculature.
We discuss here the state of the art of cardiac tissue engineering, and focus on
the ”biomimetic” aproach that reproduces in vitro  by using cells, scaffolds and
bioreactors  some of the conditions present during normal tissue development.
2. BIOMIMETIC APPROACH
The overall objective of tissue engineering is the restoration of normal tissue
function. A damaged tissue should ideally be replaced by an engineered graft that
can reestablish appropriate structure, composition, cell signaling and key func-
tion(s) of the native tissue. In light of this paradigm, the clinical utility of tissue en-
gineering will likely depend on our ability to replicate the site-specific properties
of the tissue being replaced (biochemical composition, architectural organization,
function), maintain the specific cell phenotype, and provide integration (structural
and functional) with the host tissues.
In vivo, the processes of cell differentiation during embryogenesis and adult
tissue remodeling are directed by multiple factors acting in concert and according
to specific spatial and temporal sequences (Fig. 1). Undifferentiated (stem) cells
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Fig. 1. Developmental paradigm. Tissue development and remodeling, in vivo and in vitro in-
volves the proliferation and differentiation of stem/progenitor cells and their subsequent assem-
bly into a tissue structure. Cell function and the progression of tissue assembly depend on: (a) the
availability of a scaffold for cell attachment and tissue formation, (b) the maintenance of physio-
logical conditions in cell/tissue environment, (c) supply of nutrients, oxygen, metabolites and
growth factors, and (d) presence of physical regulatory factors.
first differentiate into specific cell lineages (bone, muscle, nerves, blood vessels)
and then undergo functional asssembly into tissue structures. In most cases, tissues
contain more than one cell type and vascular supply. Both phases depend on at least
four gorups of factors: (a) a structural template for cell attachment and tissue for-
mation, (b) a physiological milieu, (c) exchange of nutrients, oxygen and metabo-
lites, and (b) physical regulatory signals.
A ”biomimetic” aproach to tissue eingineering attempts to mimic in vitro cer-
tain aspects of the environment present in vivo during normal development, in or-
der to stimulate functional assembly of the cells into specialized tissues .This gen-
erally involves the presence of reparative cells (the actual ”tissue engineers”), the
use of scaffolds (designed to provide a structural and logistic template for tissue
development and biodegrade at a controlled rate), and bioreactors (designed to
control cellular microenvironment, facilitate mass transport to the cells, and pro-
vide the necessary biochemical and physical regulatory signals) (Fig. 2). Dissoci-
ated cells are first seeded onto a three-dimensional scaffold and then cultured in a
bioreactor. Together, the scaffold and bioreactor provide biophysical regulation of
the cell environment.
Cardic muscle in unique in many respects, and represents a major challenge to
tissue engineering. Some of the key features of native cardiac muscle, and the corre-
sponding requirements for engineered cardiac muscle are summarized in Table I.
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Fig. 2. Tissue engineering paradigm. The regulatory factors of cell differentiation and tissue as-
sembly depicted in Fig. 1 can be utilized in vitro to engineer functional tissues by an integrated
use of isolated cells, biomaterial scaffolds and bioreactors. The cells themeslves (either
differentiated or progenitor/stem cells seeded onto a scaffold and cultured in a bioreactor) carry
out the porcess of tissue formation, in response to regulatory signals. The scaffold provides a
structural, mechanical and logistic template for cell attachment and tissue formation. The
bioreactor provides the environmental conditions and regulatory signals (biochemical and physi-
cal) that induce, enhance or at least support the development of functional tissue constructs.
TABLE I. Biomimetic approach to cardiac tissue engineering: main factors of the in vivo myocardial
environment and their in vitro counter parts
In vivo In vitro
Cells High density (108 cels/cm3) High density (0.3x108 cells/cm3)
Multiple cell types (cardiac myocytes,
fibroblasts, endothelial cells)
Multiple cell types (cardiac myocytes,
fibroblasts, endothelial cells)
Geometry Capillary network (7 m diameter, 30
m spacing)
Parallel channel array (100300 m di-
ameter, 100300 m spacing)
Mass transport Convection: Blood flow 500 m/s,
Diffusion in tissue space
Convection: Medium flow 50500 m/s
Diffusion in construct space
Oxygen carrier Hemoglobin (arterial blood) O2 dissol-
ved in plasma 130M O2 as oxyhe-
moglobin 8500 M O2 total 8630 M
PFC emulsion (5.4 vol% at 160 mmHg
and 37 oC) O2 dissolved in aqueous
phase 220 M O2 in PFC droplets 230
M O2 total 450 M
Physical signals Excitation (by electrical signals from pa-
cer cells); synchronous contractions. Ele-
ctro-mechanical cell coupling (gap jun-
ctions; contractile apparatus)
Electrical stimulation (by suprathreshold
pacing signals) of cultured constructs;
synchronous contractions. Electro-me-
chanical cell coupling
The cardiac myocyte is the most physically energetic cell in the body, con-
tracting more than 3 billion times in an average human lifespan, and pumping over
7,000 liters of blood per day along 100,000 miles of blood vessels. Heart muscle
contains three major subpopulations of cells  cardiac myocytes, fibroblasts and
endothelial cells  at a total concentration of approximately 100 million cells/cm3.
Due to its extremely high cell density, and high respiration rates of the cells, car-
diac muscle is highly metabolically active, consumes large amounts of oxygen,
and cannot tolerate hypoxia for prolonged periods of time.29,30 Therefore nutri-
ents, particularly oxygen, are depleted within a relatively thin layer of viable tis-
sue, and viable cells are concentrated mostly in the peripheral region of the con-
struct. Natural myocardium obviates this difficulty through a rich vasculature, with
average capillary-to-capillary distances in rat heart of only 17  19 m, approxi-
mately the width of an individual cardiac myocyte.3134
Oxygen supply to cardiac cells is provided by hemoglobin an oxygen carrier
(please note that hemoglobin increases the amount of oxygen in blood by two or-
ders of magnitude, Table I). In engineered cardiac muscle, one can mimic blood
flow through the capillary network by culturing cells on scaffolds that contain an
array of channels that are perfused with culture medium.38 Synthetic oxygen carri-
ers, such as perfluorocarbons, can be supplemented to culture medium in order to
increase its oxygen-carrying capacity.
In addition, cardiac cells do not proliferate, such that any loss of the cells is
permanent. Cell requirements for cardiac tissue engineering thus include the estab-
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lishment and maintenance of physiologically high density of viable cells and cell
co-culture.
Contraction of the cardiac muscle is driven by the waves of electrical excita-
tion generated by pacing cells that spread rapidly along the membranes of adjoin-
ing cardiac myocytes and trigger release of calcium, which in turn stimulates
contraction of the myofibrils. Electro-mechanical coupling of the myocytes is cru-
cial for their contractile function.35 To enhance the establishment of functional
connections, cells cultured on scaffolds can be stimulated by electrical signals sim-
ilar to those in the native heart,14 or subjected to direct mechanical stimulation.18
In either case, it is esential that the cells become electromechanically coupled and
capable of synchronously responding to electrical pacing signals, rather than
contracting spontaneously.
Therefore, a ”biomimetic” approach to engineering of functonal equivalents
of native myocardium should provide several physiologically relevant features:
 Structural template for tissue formation, in form of porous biodegradable
polymer scaffold with large (100 m) interconnected pores and an array of
channels (180 m in diameter)
 Physiologically high and spatially uniform seeding density of cardiac myo-
cytes in scaffold pores (to obtain compact tissue and promote cellcell inter-
actions)
 Endothelial cell lining of channels to provide paracrine signals, enhance
construct angiogenesis, and protect cardiac myocytes from hydrodynamic
shear
 Convective flow through scaffold channels (to enhance mass transport of nu-
trients, oxygen and metabolites)
 Control of medium composition, pH and oxygen levels via gas and medium
exchange, and supplementation with perfluorocarbons to increase oxygen
contents
 Electrical stimulation at a physiologic frequency and supra-threshold ampli-
tude (to promote excitation-contraction cell coupling and thereby enhance
functional assembly of engineered tissue).
3. PHYSIOLOGICAL CELL DENSITY
The technique of seeding that was specifically developed for cardiac tissue en-
gineering involves (a) rapid inoculation of cardiac cells into collagen sponges us-
ing Matrigel as a cell delivery vehicle, and (b) transfer of inoculated scaffolds
into perfused cartridges with immediate establishment of the interstitial flow of
culture medium. Forward-reverse flow was used for the initial period of 1.5  4.5 h
in order to further increase the rate and spatial uniformity of cell seeding.27
Uniderectional flow of culture medium was maintained for the duration of cultiva-
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tion. In this system, cells were ”locked” into the scaffold during a short (10 min)
gelation period, and supplied with oxygen at all times during culture.
Cell distributions in the top, center and bottom areas of a 0.65 m wide strip
extending from one construct surface to the other are shown in Fig. 3. Constructs
seeded in dishes had most cells located in the  100 m thick layer at the top sur-
face, and only a small number of cells penetrated the entire construct depth. Con-
structs seeded in perfusion had high and spatially uniform cell density throughout
the perfused volume of the construct (Fig. 3). Clearly, medium perfusion during
seeding was key for engineering thick constructs with high densities of viable
cells, presumably due to enhanced transport of oxygen within the construct.
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Fig. 3. Effects of perfusion during seeding and cultivation on cardiac cell distribution. Cross-sec-
tions of constructs inoculated with 12 million cells and then transferred for a period of 4.5 h either
into dishes (25 rpm, left) or into perfused cartidges (1.5 ml/min, right). The top, center and bottom
areas of a 650 m wide strip extending from one construct surface to the other are shown. Scale bar
100 m (with permission from Radisic et al. Biotech. Bioeng. 82 (2003) 403  414 (Fig. 4)).
Throughout the cultivation, the number of live cells in perfused constructs was
significantly higher than in dish-grown constructs. Importantly, the final cell viabil-
ity in perfused constructs (81.6  3.7 %) was not significantly different than the via-
bility of the freshly isolated cells (83.8  2.0) and it was markedly higher than the cell
viability in dishgrown constructs (47.4  7.8 %).38 Consistently, the mole ratio of
lactate produced to glucose consumed (L/G) was  1 for perfused constructs, indicat-
ing aerobic cell metabolism. In dishes, L/G increased progressively from 1 to  2, in-
dicating a transition to anaerobic cell metabolism. Cell damage, assessed by moni-
toring the activity of lactate dehydrogenase (LDH) in culture medium, was at all time
points significantly lower in perfusion than in dish cultures.
Perfused constructs and native ventricles had more cells in the S phase than in
the G2/M phase, whereas the cells from dish-grown constructs appeared unable to
complete the cell cycle and accumulated in the G2/M phase. Cells expressing car-
diac-specific differentiation markers (sarcomeric -actin, sarcomeric tropomyo-
sin, cardic tropolin I) were present throughout the perfused constructs, and only
within a  100 m thick surface layer in dish-grown constructs.
Spontaneous contractions were observed in some constructs early in culture,
and ceased after approximately 5 days of cultivation, indicating the maturation of
engineered tissue. In response to electrical stimulation, perfused construcst con-
tracted synchronously, had lower excitation thresholds and recovered their base-
line function levels following treatment with a gap junction blocker, dish-grown
constructs exbibited arrhythmic contractile patterns and failed to recover their
baseline levels.
Although interstitial medium flow enabled engineering of compact tissue that
had physiologic density of viable aerobically metabolizing cells, most cells were
round and mononucleated. This was likely due to the exposure of cardiac myocytes
to hydrodynamic shear, in contrast to the native heart muscle where blood is con-
fined within the capillary bed and therefore not in direct contact with cardiac
myocytes. This motiviated the design of scaffolds with arrays of channels that pro-
vide a separate compartment for medium flow.
4. OXYGEN SUPPLY
To test the feasibility of using channeled scaffolds, cardiac constructs were
first engineering using a channeled collagen scaffold (UltrafoamTM, 1 cm in diam-
eter x 3 mm thisk) seeded with neonatal cardiac myocytes and cultivated in perfu-
sion at 0.5 ml/min for 10 days. The channel maintained its initial diameter and was
surrounded with a 300 m thick tissue layer. However, collagen is not optimal for
cardiac tissue engineering due to its poor structural integrity. We thus explored the
use of an elastomer, poly(glycerol sebacate), PGS,5 pretreated with neonatal rat
cardiofibroblasts for 3 days in orbitally mixed dishes, followed by addition of rat
cardiomyocytes and perfusion cultivation.38 After only 3 days of culture, cells on
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scaffolds formed constructs that contracted synchronously in response to electrical
stimulation. The scaffold pores remained open and the pressure drop measured
ascross the construct was as low as 0.1 kPa/mm.
PGS is obtained by condensation of glycerol and sebacic acid, and formed by
salt-leaching into a three-dimensional network with a desired pore size (e.g.,  100
m), porosity ( 95%) and thickness (1  5 mm). The cross-linked and hydrogen
bonds contirbute to its unique elastic properties. PGS degrades by hydrolysis of its
ester bond into glycerol (likely adsorbed in the body) and sebacic acid (secreted by
urine either directly or metabolized into carboxylic acids). In vivo (5 weeks of sub-
cutaneous implantation), PGS scaffold was biocompatible and lost its mass lineary
(to  20 % of initial over 5 weaks), such that its shape and structural integrity were
well maintained. In contrast, poly-lactide-glycolide (PLG) had abrupt loss of
weight after an initial lag phase.18 In vitro (in buffer, at 37 oC) PGS degraded more
slowly (to  80 % of initial over 8 weeks if unseeded, to 65 % of initial if seeded
with hepatocytes). The mechanical properties of PGS resemble vulcanized rubber:
PGS is highly elastic and capable of up to 400 % elongation before it yields.
To mimic the capillary network, neonatal rat heart cells were cultured on PGS
scaffolds with a parallel array of channels made using a laser cutting/engraving
sysem (Fig. 4C) and perfused with culture medium. To mimic oxygen supply by
hemoglobin, culture medium was supplemented by 5.4 %v/v PFC emulsion (17
vol% OxygentTM, kindly donated by Alliance Pharmaceuticals Corp. (San Diego
CA)); constructs perfused with unsupplemented culture medium served as con-
trols. Construcs were subjected to unidirectional medium flow at a flow rate 0.1
ml/min provided by a multi-channel peristaltic pump (Isma Tec) (Fig. 4A).
As the medium flowed through the channel array, oxygen was depleted from the
aqueous phase of the culture medium by diffusion into the construct space where it was
used for cell respiration (Fig 4B). Depletion of oxygen in the aqueous phase acted as a
driving force for the diffusion of dissolved oxygen from the PFC particles, thereby
contributing to the maintenance a higher oxygen concentrations in the medium. Due to
the small size of PFC particles, the passive diffusion of dissolved oxygen from the PFC
phase into the aqueous phase was very fast, and estimated not to be a rate-limiting step
in this system.38 For comparison, in un-supplemented culture medium, oxygen was
depleted faster since there was no oxygen carrier phase that acts as a reservoir.37
In PFC-supplemented medium, the decrease in the partial pressure of oxygen
in the aqueous phase was only 50 % of that in control medium (28 mmHg vs. 45
mm Hg between the construct inlet and outlet at the flow rate of 0.1 ml/min). Con-
sistently, constructs cultivated in the presence of PFC had higher amounts of DNA,
troponin I and Cx-43, and significantly better contractile properties as compared to
control constructs. In both groups, cells were present at the channel surfaces as
well as within constructs. Improved construct properties were correlated with the
enhanced supply of oxygen to the cells within constructs.
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In order to rationalize experimental data for oxygen transport and consumption
in engineered cardiac constructs with an array of channels, we developed a mathe-
matical model of oxygen distribution in cardiac constructs similar to the Krogh cyl-
inder model. Concentration profiles of oxygen and cells within the constructs were
obtained by numerical simulation of the diffusive-convective oxygen transport and
its utilization by the cells. The model was used to evaluate the effects of medium per-
fusion rate, oxygen carrier and scaffold geometry on viable cell density.38
The model was used to define scaffold geometry and flow conditions necessary to
cultivate cardiac constructs with clinically relevant thicknesses (5 mm). Oxygen pro-
files were modeled in a channel array consisting of channels 100 m in diameter and
100 m wall-to-wall spacing at physiologically high cell density 1 	 108 cells/cm3. At
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Fig. 4. Channeled scaffolds and oxygen carriers. (A). Perfusion loop. Channeled biorubber scaf-
folds (7) preconditioned with cardiac fibroblasts were seeded with cardiac myocytes and placed
into perfusion cartridges (4) between two syringes (5,6). Medium flow (0.1 ml/min) was provided
by a multi-channel peristaltic pump (1) and gas exchange was provided by a coil of thin silicone
tubing (3 m long) (2). (B) Modes of oxygen transport in the channeled construct perfused with
culture medium include convection through the channel lumen and diffusion into the construct
space surrounding each channel. In regular culture medium (control group, shown on left) oxy-
gen dissolved in the aqueous phase during gas exchange in the external loop is transported into
the tissue phase and consumed by the cells. In culture medium supplemented by 5.4 vol%
perfluorocarbon (PFC) emulsion (PFC group, shown on right), oxygen is replenished within the
tissue construct by the release of oxygen from the PFC particle into the culture medium phase, by
a process governed by Henry’s law.38 (C) Scanning electron micrograph of a channeled PGS
scaffold. Scale bar 500 m.
0.049 cm/s oxygen concentration increased significantly in both tissue space and
channel lumen with the increase in circulating PFC emulsion from 0 to 6.4 vol%. Al-
though the oxygen concentration in the tissue space with physiological cell density
increased considerably with the increase of circulating PFC concentration from
06.4 %, we had to increase the flow rate, keeping the shear stress in the physiologi-
cal range  1 dyn/cm2, in order to provide enough oxygen for the entire 0.5 cm thick
construct. At our best conditions (0.135 cm/s and 6.4 % PFC) oxygen is not depleted
at any point in the scaffold and the minimum concentration of 33 ‚ M is approxi-
mately five times above the Km (oxygen concentration at which consumption rate in
the tissue space is maintained at a maximum level).
5. EXCITATION–CONTRACTION COUPLING
Mechanical stimulation. One significant approach to cardiac tissue engineer-
ing, established by Eschenhagen and colleagues1518 involves the cultivation of
neonatal rat heart cells in collagen gel or Matrigel, in the presence of growth fac-
tors. The cultured tissues are subjected to sustained mechanical strain. Under these
conditions, cardiomyocytes and non-myocytes from 3D cardiac organoids, con-
sisting of a well organized and highly differentiated cardiac muscle syncytium, that
exhibited contractile and electrophysiologicl properties of working myocardium.
First implantation expreriments in healthy rats showed survival, strong vascu-
larization, and signs of terminal differntiation of cardiac tissue grafts.
In one set-up, neonatal rat ventricular myocytes were resuspended in a gel con-
sisting of collagen I and Matrigel in culture medium16 and cast into wells containing
Velcro coated silicione tubes. After 4 days in culture a strip of biconcave tissue was
formed fixed at each side to a piece of silicone tubing. Unidirectional and cyclic stretch
at the frequency of 1.5 Hz and the strain rate of up to 20 % was employed for 6 days.
Stretched constructs exhibited improved morphology and organization of cardiac
myocytes, higher RNA/DNAand protein/cell raitos, and higher force of contraction.16
In an improved set-up, neonatal rat cardiac cells were suspended in the colla-
gen/Matrigel mix and cast into circular molds.18 After 7 days of static culture, the
strips of cardiac tissue were placed around two rods of a custom made mechanical
stretcher and subjected to either unidirectional or cyclic stretch. Histology and
immunohistochemistry revealed formation of intensively interconnected, longitu-
dinally oriented cardiac muscle bundles with morphological features resembling
adult rather than immature native tissue. Primitive capillary structures were also
detected. Cardiomyocytes exhibited well developed ultrastructural features: sarco-
meres arranged in myofibrils, with well developed, Z, I, A H and M bands, special-
ized cell-cell junctions, T tubules as well as well developed basement membrane.
Contractile properties were similar to those measured for native tissue, with high
ratio of twich to resting tension and strong 
-adrenegenic response. Action potenti-
als characteristic of rat ventricular myocytes were recorded.
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Electrical simulation. Although the application of cyclic mechanical stretch
alone substantially improved cell differentiation and force of contraction, the dis-
tribution of gap junctions remained unclear, and some hallmarks of cardiac devel-
opment are missing, most critacally the M bands and IC discs.18 In native heart,
mechanical stretch is induced by electrical signals. The orderly coupling between
electrical pacing signals and macroscopic contractions is crucial for the develop-
ment and function of native myocardium.35 In a recent study, we hypothesized that
applying electrical signals designed to induce synchronous construct contractions
would enhance cell differentiation and functional assembly of engineered tissue
via physiologically relevant mechanism. To test this hypothesis, cardiac constructs
prepared by seeding collagen sponges (6 	 8 	 1.5 mm) with neonatal rat ventricu-
lar cells (5 	 106) were stimulated using supra-threshold square biphasic pulses (2
ms duration, 1 Hz, 5 V). The stimulation was initiated after 1  5 days of scaffold
sedding (3 day period was optimal) and applied for up to 8 days.
Over only 8 days in vitro, electrical fild stimulation induced cell alignment and
coupling, increased the amplitude of synchronous construct contractions by a factor
of 7 and resulted in a remarkable level of ultrastructural organization. Development
of conductive and contractile properties of cardiac constructs was concurrent, with
strong dependence on the initation and duration of electrical stimulation.
The application of electrical stimulation during construct cultivation markedly
enhanced the contractive behaviour. After 8 days of culture, the amplitude of con-
tractions was 7-fold higher in stimulated than non-stimulated constructs (Fig. 5a), a
result of the progressive increase with the duration of culture. The excitation thresh-
old (ET, the minimum voltage at which the entire construct was observed to beat) de-
creased (Fig. 5B) and the maximum capture rate (MCR the maximum pacing fre-
quency for synchronous construct contractions), increased (Fig. 5C) both with time
and due to electrical stimulation, suggesting functional coupling of the cells. The
shape, amplitude (100 mV), and duration (200 ms) of the electrical activity re-
corded for cells in constructs stimulated during culture were similar to action poten-
tials reported for constructs that were mechanically stimulted during culture.18
On a molecular level, electrical stimulation elevated the levels of all measured
cardiac proteins and enhanced the expression of the corresponding gens, without
causing pathological cell hypertrophy.39 With time in culture, the ratio of mature
and immature form of myosin heavy chain (-MHC and 
-MHC, respectively) de-
creased in non-stimulated and increased in stimulated constructs, suggesting that
the maturation of cardiomyocytes depended both on culture duration and electrical
stimulation.
After 8 days, stimulated constructs demonstrated a remarkable level of ultra-
structurl differentiation, comparable in several respects to that of native myocar-
dium. Cells in stimulted constructs were aligned, elongated, and contained cen-
trally positioned elongated nuclei, in contrast to round cells in non-stimulated con-
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structs that had a high nucleus-to-cytoplasm ratio. Stimulated constructs and neo-
natal ventricles contained abundant mitochondria positioned between myofibrils,
in contrast to non-stimulated constructs containing mitochondria scattered around
the cytoplasm, and substantially larger amounts of glycogen. Electrical stimulation
induced the development of long, well aligned registers of sarcomers that closely
resembled those in native myocardium (Fig. 5D) representing a hallmark of matur-
ing cardiomyocytes.35 The volume fraction of sarcomeres in stimulated 8-day con-
structs was indistinguishable from that measured for neonatal ventricles,40 in con-
trast, non-stimulated constructs contained only scattered and poorly organized
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Fig. 5. Effects of electrical stimulation on funcitonal assembly of engineered cardiac constructs.
(A) Contraction amplitude of constructs cultured for a total of 8 days, shown as a fractional
change in the construct size. Electrical stimulation increased the amplitude of contractions by a
factor of seven. (B) Excitation threshold (ET) decreased and (C) Maximum cupture rate (MCR)
increased significantly both with time in culture and due to electrical stimulation. (*) Denotes sta-
tistically significant differenses (P  0.05; Tukey’s post-hoc test with one-way ANOVA, n = 5 
10 samples per group and time point). (D) The structure of sarcomeres and (E) gap junctions ob-
served in micrographs of stimulated constructs after 8 days of cultivation were remarkably simi-
lar to neonatal rat ventricles and markedly better developed than in control (non-stimulated) con-
structs.
sarcomers. In stimulated constructs intercalated discs were positioned between
aligned Z lines (Fig. 5E) and were as frequent as in neonatal ventricles; gap junc-
tions were also substantially better developed and more frequent.
Myofibers aligned in the direction of the electrical field lines, possibly in an
attempt to decrease the apparent ET in response to pacing.41 In contrast, cells is
non-stimulated constructs stayed round and expressed relatively low levels of car-
diac markers. After 8 days, stimulated constructs exhibited markedly higher
density of Cx-43 than either early (3-day) or non-stimulted constructs. Notably,
improved contractile properties of electrically stimulated constructs were not re-
flected in any apparent differences in construct cellularity, cell damage or cell me-
tabolism, but correlated instead with cell differentiation. Stimulted constructs and
neonatal ventricles expressed high levels of cardiac Tn-I, sarcomeric -actin,
-MHC and 
-MHC, and contained elongated cells aligned in parallel. In contrast,
cells in non-stimulated constructs stayed round and expressed relatively low levels
of cardiac markers. Cross striations charcteristic for mature cardiac myocytes were
detected in stimulated constructs and native ventricles, but not in non-stimulated
constructs.
These studies suggest that electrical stimulation of construct contractions dur-
ing cultivation progressively enhanced the excitation-contraction coupling and im-
proved the properties of engineered myocardium at the cellular, ultrastructural and
tissue levels.
SUMMARY
The paradigm discussed in this chapter is that immature but functional cardiac
tissue constructs can be grown in vitro using culture systems based on scaffolds
and bioreactors designed to recapitulate some of the factors present during normal
tissue development. These constructs are expected to have the ability to regenerate
the molecular, structural and functional properties of a compromised native tissue.
Engineered tissues can also serve as high-fidelity models for basic studies of cells
and tissues. Key factors that determine the biophysical regulation of cell function
and tissue assembly include: (a) physiologically high density of heart cells, (b)
scaffolds that are tailored to structurally and mechanically support cell attachment,
coupling and mechanotransduction, (c) bioreactors designed to control cellular
microenvironment, (d) application of biochemical and physical regulatory signals,
and (e) establishment of a vascular network than can facilitate integration into the
host.
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Sr~ano tkivo ima kompaktnu izuzetno slo`enu strukturu sa visokom gustinom
}elija (100 miliona po cm3) koje su funkcionalno povezane i kucaju sinhronizovano
u odgovoru na elektri~ne signale. Efikasan transport kiseonika i elektri~na sti-
mulacija su presudni za normalan razvoj i funkciju sr~anog mi{i}a. Na{a hipoteza je
da su ista ta dva faktora presudna i za kultivaciju sr~anog tkiva in vitro. ]elije
izolovane iz sr~anog tkiva pacova su gajene na polimernoj matrici (porozni kolagen;
sinteti~ki porozni elastomer sa mre`om kanala) u dva razli~ita sistema: (1) sa
perfuzijom medijuma kroz mre`u kanala (surogat kapilara) uz dodatak perfluoro-
karbona (surogat hemoglobina), i (2) sa elektri~nom stimulacijom (surogat normalne
sr~ane aktivnosti). Perfuzija i elektri~na stimulacija su zna~ajno poboq{ale
sastav i strukturu tkiva, ja~inu i sinhronizaciju kontrakcija u odgovoru na elektri-
~ne signale. Tokom samo 8 dana kultivacije, dobijeno je tkivo koje ima niz osobina
normalnog sr~anog mi{i}a, a podr`ava tezu da sistemi za kultivaciju tkiva treba da
imitiraju, u najv}eoj mogu}oj meri, uslove koji postoje tokom normalnog razvoja.
(Primqeno 29. decembra 2004)
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